Financials
- Market Capitalization 2.41 B
- Employee 13
- Founded 2006
- CEO Angelos M. Stergiou
- Website www.sellaslifesciences.com
- Headquarter Delaware, United States
- FIGI BBG000VC77H7
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-15.08
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1787 | NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | 21.25 USD | -1.53% | -7.85% | -7.29% | -41.41% | 2.54 B USD | ||
| 1803 | LQDA Liquidia Corporation - Common Stock | 27.67 USD | +1.06% | -1.00% | -58.57% | +22.43% | 2.48 B USD | ||
| 1847 | IRON Disc Medicine, Inc. - Common Stock | 60.48 USD | -2.55% | -5.05% | -13.67% | -15.40% | 2.32 B USD | ||
| 1851 | CLDX Celldex Therapeutics, Inc. - Common Stock | 29.43 USD | -1.54% | -9.94% | -21.31% | +8.04% | 2.31 B USD |